Joe Guydish, PhD

Title(s)Professor, Institute for Health Policy Studies
SchoolSchool of Medicine
Address490 Illinois Street
San Francisco CA 94158
Phone415-476-0954
ORCID ORCID Icon0000-0003-2115-3340 Additional info
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Marketing, FDA communication, tobacco perceptions and use in addiction treatment
    NIH R01DA036066Sep 30, 2013 - Aug 31, 2017
    Role: Principal Investigator
    Impact of Core Implementation Components on Adoption
    NIH R01DA025600Aug 1, 2009 - Jul 31, 2011
    Role: Principal Investigator
    Organizational Change and Nicotine Dependence Treatment
    NIH R01DA020705Apr 20, 2006 - Mar 31, 2012
    Role: Principal Investigator
    Integrating Multi-Assessment Protocols into Practice
    NIH R01DA014470Aug 25, 2001 - Jul 31, 2006
    Role: Principal Investigator
    DRUG ABUSE TREATMENT--DEMAND IMPACTS IN SAN FRANCISCO
    NIH R01DA012221Jan 1, 1999 - Dec 31, 2001
    Role: Principal Investigator
    Treatment for Complex Patients: Continuing and Extended Care
    NIH P50DA009253Sep 29, 1994 - May 31, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pre-implementation Assessment of Tobacco Cessation Interventions in Substance Use Disorder Residential Programs in California. Subst Use Misuse. 2022 May 27; 1-11. Fokuo JK, McCuistian CL, Masson CL, Gruber VA, Straus E, Wong J, Guydish JR. PMID: 35621319.
      View in: PubMed   Mentions:
    2. Acceptability and participation predictors for a pragmatic randomized controlled trial to test a smoking cessation intervention after discharge from mental health wards. Drug Alcohol Depend. 2022 05 01; 234:109390. Martínez C, Feliu A, Torres N, Nieva G, Pinet C, Raich A, Mondon S, Barrio P, Andreu M, Hernández-Ribas R, Vicens J, Costa S, Suelves JM, Vilaplana J, Enríquez M, Alaustre L, Vilalta E, Subirà S, Bruguera E, Castellano Y, Saura J, Guydish J, Fernández E, Ballbè M. PMID: 35278807.
      View in: PubMed   Mentions:
    3. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. J Psychoactive Drugs. 2022 Jan 27; 1-4. Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. PMID: 35083957.
      View in: PubMed   Mentions:
    4. Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds. J Subst Abuse Treat. 2022 04; 135:108640. McCuistian C, Kapiteni K, Le T, Safier J, Delucchi K, Guydish J. PMID: 34743925; PMCID: PMC8903046.
      View in: PubMed   Mentions:
    5. Racial/Ethnic Differences in Tobacco Use and Cessation Services among Individuals in Substance Use Treatment. J Psychoactive Drugs. 2021 Nov-Dec; 53(5):483-490. McCuistian C, Le T, Delucchi K, Pagano A, Hosakote S, Guydish J. PMID: 34672862; PMCID: PMC8959398.
      View in: PubMed   Mentions:    Fields:    
    6. Factors associated with dual and polytobacco use among people in residential substance use disorder treatment. Am J Addict. 2021 09; 30(5):496-504. Nguyen N, Kapiteni K, Straus ER, Guydish J. PMID: 34427005.
      View in: PubMed   Mentions:    Fields:    
    7. Adaptation to family-based treatment for Medicaid-insured youth with anorexia nervosa in publicly-funded settings: Protocol for a mixed methods implementation scale-out pilot study. J Eat Disord. 2021 Aug 13; 9(1):99. Accurso EC, Mu KJ, Landsverk J, Guydish J. PMID: 34389052; PMCID: PMC8360814.
      View in: PubMed   Mentions:
    8. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs. Drug Alcohol Depend. 2021 08 01; 225:108812. Masson CL, McCuistian C, Straus E, Elahi S, Chen M, Gruber VA, Le T, Guydish J. PMID: 34174773; PMCID: PMC8221747.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients. J Subst Abuse Treat. 2022 01; 132:108496. Guydish J, Le T, Hosakote S, Straus E, Wong J, Martínez C, Delucchi K. PMID: 34111773.
      View in: PubMed   Mentions:    Fields:    
    10. Correlates of e-cigarette use for smoking cessation among clients in residential substance use disorder treatment. Addict Behav. 2021 08; 119:106947. Masson CL, Le T, Hosakote S, Fokuo JK, Gubner NR, Shingle M, Guydish J. PMID: 33892312; PMCID: PMC8247797.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Impacts of COVID-19 on residential treatment programs for substance use disorder. J Subst Abuse Treat. 2021 04; 123:108255. Pagano A, Hosakote S, Kapiteni K, Straus ER, Wong J, Guydish JR. PMID: 33375986; PMCID: PMC7953585.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Menthol cigarette use in substance use disorder treatment before and after implementation of a county-wide flavoured tobacco ban. Tob Control. 2021 11; 30(6):616-622. Guydish JR, Straus ER, Le T, Gubner N, Delucchi KL. PMID: 33177211; PMCID: PMC8110613.
      View in: PubMed   Mentions:    Fields:    
    13. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. J Subst Abuse Treat. 2020 11; 118:108097. Satre DD, Palzes VA, Young-Wolff KC, Parthasarathy S, Weisner C, Guydish J, Campbell CI. PMID: 32972648; PMCID: PMC7519171.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Tobacco use and tobacco services in California substance use treatment programs. Drug Alcohol Depend. 2020 09 01; 214:108173. Guydish J, Kapiteni K, Le T, Campbell B, Pinsker E, Delucchi K. PMID: 32693199; PMCID: PMC7439769.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    15. Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment. J Subst Abuse Treat. 2020 09; 116:108064. Campbell BK, Le T, Kapiteni K, Gubner NR, Guydish J. PMID: 32741500; PMCID: PMC7399210.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Factors associated with receipt of the 5As model of brief intervention for smoking cessation among hospitalized patients. Addiction. 2020 11; 115(11):2098-2112. Martínez C, Feliu A, Castellano Y, Fu M, Fernández P, Cabrera-Jaime S, Puig-Llobet M, Galimany J, Guydish J, Fernández E, ETHIF Research Group. PMID: 32297373.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Association of Medicaid Expansion and Health Insurance with Receipt of Smoking Cessation Services and Smoking Behaviors in Substance Use Disorder Treatment. J Behav Health Serv Res. 2020 04; 47(2):264-274. Yip D, Gubner N, Le T, Williams D, Delucchi K, Guydish J. PMID: 31359228; PMCID: PMC6986987.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Tobacco-free grounds implementation in California residential substance use disorder (SUD) treatment programs. J Addict Dis. 2020 Jan-Mar; 38(1):55-63. Guydish J, Wahleithner J, Williams D, Yip D. PMID: 32186480.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    19. Patient perceptions of tobacco control after smoke-free hospital grounds legislation: Multi-center cross-sectional study. Int J Nurs Stud. 2020 Feb; 102:103485. Martínez C, Castellano Y, Fu M, Riccobene A, Feliu A, Tigova O, Ballbè M, Anton L, Fernández P, Cabrera-Jaime S, Puig-Llobet M, Moreno C, Falcó-Pegueroles A, Galimany J, Estrada JM, Guydish J, Fernández E, ETHIF Research Group. PMID: 31862532.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    20. Recent cessation attempts and receipt of cessation services among a diverse primary care population - A mixed methods study. Prev Med Rep. 2019 Sep; 15:100907. Gubner NR, Williams DD, Chen E, Silven D, Tsoh JY, Guydish J, Vijayaraghavan M. PMID: 31193606; PMCID: PMC6536779.
      View in: PubMed   Mentions: 1  
    21. Smoking related outcomes before and after implementation of tobacco-free grounds in residential substance use disorder treatment programs. Drug Alcohol Depend. 2019 04 01; 197:8-14. Gubner NR, Williams DD, Le T, Garcia W, Vijayaraghavan M, Guydish J. PMID: 30743196; PMCID: PMC6440856.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    22. Tobacco Cessation Services in Addiction Treatment: What Do Clients Say? Psychiatr Serv. 2019 03 01; 70(3):229-232. Guydish J, Yip D, Le T, Gubner NR, Williams DD, Delucchi KL. PMID: 30630403.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Effectiveness of a telephone-based intervention for smoking cessation in patients with severe mental disorders: study protocol for a randomized controlled trial. Trials. 2019 Jan 11; 20(1):38. Ballbè M, Martínez C, Feliu A, Torres N, Nieva G, Pinet C, Raich A, Mondon S, Barrio P, Hernández-Ribas R, Vicens J, Costa S, Vilaplana J, Alaustre L, Vilalta E, Blanch R, Subirà S, Bruguera E, Suelves JM, Guydish J, Fernández E. PMID: 30635072; PMCID: PMC6329054.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    24. Sex Differences in Graphic Warning Label Ratings by Addictions Clients. Tob Regul Sci. 2019 Jan; 5(1):3-14. Campbell BK, Le T, Yip D, Griffin KB, Gubner NR, Guydish JR. PMID: 31236435; PMCID: PMC6590904.
      View in: PubMed   Mentions: 1  
    25. Relationship between Tobacco Use and Health-Related Quality of Life (HRQoL) among Clients in Substance Use Disorders Treatment. J Psychoactive Drugs. 2019 Jan-Mar; 51(1):48-57. Campbell B, Yip D, Le T, Gubner N, Guydish J. PMID: 30570409; PMCID: PMC6417885.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Health risk perceptions and reasons for use of tobacco products among clients in addictions treatment. Addict Behav. 2019 04; 91:149-155. Campbell BK, Le T, Gubner NR, Guydish J. PMID: 30206006; PMCID: PMC6474775.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. Differences in tobacco use prevalence, behaviors, and cessation services by race/ethnicity: A survey of persons in addiction treatment. J Subst Abuse Treat. 2018 11; 94:9-17. Pagano A, Gubner NR, Le T, Yip D, Williams D, Delucchi K, Guydish J. PMID: 30243423; PMCID: PMC6203319.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. A Comparison of Daily Versus Weekly Electronic Cigarette Users in Treatment for Substance Abuse. Nicotine Tob Res. 2018 04 02; 20(5):636-642. Gubner NR, Pagano A, Tajima B, Guydish J. PMID: 28575519; PMCID: PMC5892852.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients. Nicotine Tob Res. 2018 04 02; 20(5):628-635. Hall SM, Humfleet GL, Gasper JJ, Delucchi KL, Hersh DF, Guydish JR. PMID: 28549161; PMCID: PMC7207071.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. Menthol cigarette smoking among individuals in treatment for substance use disorders. Addict Behav. 2018 05; 80:135-141. Gubner NR, Williams DD, Pagano A, Campbell BK, Guydish J. PMID: 29407684; PMCID: PMC5857239.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Cigarette smoking and quit attempts among Latinos in substance use disorder treatment. Am J Drug Alcohol Abuse. 2018; 44(6):660-667. Pagano A, Gubner N, Le T, Guydish J. PMID: 29333890; PMCID: PMC6046273.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    32. Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016. Drug Alcohol Depend. 2017 10 01; 179:355-361. Guydish J, Yip D, Le T, Gubner NR, Delucchi K, Roman P. PMID: 28844012; PMCID: PMC5600495.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency. Drug Alcohol Depend. 2017 09 01; 178:267-270. Gubner NR, Guydish J, Humfleet GL, Benowitz NL, Hall SM. PMID: 28683421; PMCID: PMC5553616.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    34. Regional cerebral blood flow in opiate dependence relates to substance use and neuropsychological performance. Addict Biol. 2018 03; 23(2):781-795. Murray DE, Durazzo TC, Schmidt TP, Murray TA, Abé C, Guydish J, Meyerhoff DJ. PMID: 28627790; PMCID: PMC5736471.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Addiction Treatment Clients' Reactions to Graphic Warning Labels on Cigarette Packs. J Drug Issues. 2017 Jul; 47(3):433-447. Pagano A, Gubner N, Tajima B, Yip D, Henderson C, Guydish J. PMID: 29176913; PMCID: PMC5699470.
      View in: PubMed   Mentions: 2  
    36. Drug abuse staff and clients smoking together: A shared addiction. J Subst Abuse Treat. 2017 05; 76:64-68. Guydish J, Le T, Campbell B, Yip D, Ji S, Delucchi K. PMID: 28143680; PMCID: PMC5366098.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control. 2018 01; 27(1):43-49. Guydish J, Tajima B, Le T, Henderson C, Yip D, Gruber V, Garcia W, Delucchi KL. PMID: 27913790.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Quitting smoking during substance use disorders treatment: Patient and treatment-related variables. J Subst Abuse Treat. 2017 02; 73:40-46. Campbell BK, Le T, Tajima B, Guydish J. PMID: 28017183; PMCID: PMC5193170.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Building Tobacco Cessation Capacity in Homeless Shelters: A Pilot Study. J Community Health. 2016 10; 41(5):998-1005. Vijayaraghavan M, Guydish J, Pierce JP. PMID: 26983929.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Frontal Metabolite Concentration Deficits in Opiate Dependence Relate to Substance Use, Cognition, and Self-Regulation. J Addict Res Ther. 2016 08; 7(4). Murray DE, Durazzo TC, Schmidt TP, Abé C, Guydish J, Meyerhoff DJ. PMID: 27695638; PMCID: PMC5042152.
      View in: PubMed   Mentions: 7  
    41. Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment. Drug Alcohol Depend. 2016 Sep 01; 166:93-9. Guydish J, Tajima B, Pramod S, Le T, Gubner NR, Campbell B, Roman P. PMID: 27449271; PMCID: PMC4983463.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. Electronic-cigarette use by individuals in treatment for substance abuse: A survey of 24 treatment centers in the United States. Addict Behav. 2016 12; 63:45-50. Gubner NR, Andrews KB, Mohammad-Zadeh A, Lisha NE, Guydish J. PMID: 27423097; PMCID: PMC4993629.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    43. Smoking among patients in substance use disorders treatment: associations with tobacco advertising, anti-tobacco messages, and perceived health risks. Am J Drug Alcohol Abuse. 2016 11; 42(6):649-656. Campbell BK, Le T, Andrews KB, Pramod S, Guydish J. PMID: 27314450; PMCID: PMC5093078.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Barriers and Facilitators to Tobacco Cessation in a Nationwide Sample of Addiction Treatment Programs. J Subst Abuse Treat. 2016 08; 67:22-9. Pagano A, Tajima B, Guydish J. PMID: 27296658; PMCID: PMC4911699.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    45. A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment. J Subst Abuse Treat. 2016 Apr; 63:39-45. Guydish J, Gruber VA, Le T, Tajima B, Andrews KB, Leo H, Zura SK, Miller R, Tsoh JY. PMID: 26825975; PMCID: PMC4775306.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. An international systematic review of smoking prevalence in addiction treatment. Addiction. 2016 Feb; 111(2):220-30. Guydish J, Passalacqua E, Pagano A, Martínez C, Le T, Chun J, Tajima B, Docto L, Garina D, Delucchi K. PMID: 26392127; PMCID: PMC4990064.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    47. Prevalence and factors associated with smoking tobacco among men recently released from prison in California: A cross-sectional study. Addict Behav. 2015 Nov; 50:157-60. Howell BA, Guydish J, Kral AH, Comfort M. PMID: 26150399; PMCID: PMC4535991.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    48. The facts are clear. Addiction. 2015 Jun; 110(6):1025-6. Schroeder S, Guydish J. PMID: 25963875.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Smoking Behaviors and Attitudes Among Clients and Staff at New York Addiction Treatment Programs Following a Smoking Ban: Findings After 5 Years. Nicotine Tob Res. 2016 May; 18(5):1274-81. Pagano A, Guydish J, Le T, Tajima B, Passalacqua E, Soto-Nevarez A, Brown LS, Delucchi KL. PMID: 26014456; PMCID: PMC6407842.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Scientific writing seminar for early-stage investigators in substance abuse research. Subst Abus. 2016; 37(1):238-41. Guydish J, Masson C, Flentje A, Shopshire M, Sorensen JL. PMID: 25893689; PMCID: PMC4615274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Tobacco-related mortality among persons with mental health and substance abuse problems. PLoS One. 2015; 10(3):e0120581. Bandiera FC, Anteneh B, Le T, Delucchi K, Guydish J. PMID: 25807109; PMCID: PMC4373726.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    52. Predictors of Tobacco Use Among New York State Addiction Treatment Patients. Am J Public Health. 2015 Jan; 105(1):e57-e64. Guydish J, Yu J, Le T, Pagano A, Delucchi K. PMID: 25393179; PMCID: PMC4265922.
      View in: PubMed   Mentions: 8     Fields:    
    53. Predictors of quit attempts among smokers enrolled in substance abuse treatment. Addict Behav. 2015 Jan; 40:1-6. Martínez C, Guydish J, Le T, Tajima B, Passalacqua E. PMID: 25218064; PMCID: PMC4250286.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    54. The relationship of therapeutic alliance and treatment delivery fidelity with treatment retention in a multisite trial of twelve-step facilitation. Psychol Addict Behav. 2015 Mar; 29(1):106-13. Campbell BK, Guydish J, Le T, Wells EA, McCarty D. PMID: 25134056; PMCID: PMC4739723.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    55. Treatment adherence and competency ratings among therapists, supervisors, study-related raters and external raters in a clinical trial of a 12-step facilitation for stimulant users. J Subst Abuse Treat. 2014 Sep; 47(3):222-8. Peavy KM, Guydish J, Manuel JK, Campbell BK, Lisha N, Le T, Delucchi K, Garrett S. PMID: 25017448; PMCID: PMC4131987.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Assessment of the smoke-free outdoor regulation in the WHO European Region. Prev Med. 2014 Jul; 64:37-40. Martínez C, Guydish J, Robinson G, Martínez-Sánchez JM, Fernández E. PMID: 24704133; PMCID: PMC4102698.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    57. Does treatment fidelity predict client outcomes in 12-Step Facilitation for stimulant abuse? Drug Alcohol Depend. 2014 Jan 01; 134:330-336. Guydish J, Campbell BK, Manuel JK, Delucchi KL, Le T, Peavy KM, McCarty D. PMID: 24286966; PMCID: PMC3914731.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Commentary on Szatkowski & McNeill (2013): Where the smokers are. Addiction. 2013 Aug; 108(8):1495-6. Guydish J. PMID: 23844774; PMCID: PMC3711154.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Therapist predictors of treatment delivery fidelity in a community-based trial of 12-step facilitation. Am J Drug Alcohol Abuse. 2013 Sep; 39(5):304-11. Campbell BK, Buti A, Fussell HE, Srikanth P, McCarty D, Guydish JR. PMID: 23837717; PMCID: PMC3959728.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    60. Assessing fidelity of treatment delivery in group and individual 12-step facilitation. J Subst Abuse Treat. 2013 Feb; 44(2):169-76. Campbell BK, Manuel JK, Manser ST, Peavy KM, Stelmokas J, McCarty D, Guydish JR. PMID: 22944595; PMCID: PMC3515700.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    61. The New York policy on smoking in addiction treatment: findings after 1 year. Am J Public Health. 2012 May; 102(5):e17-25. Guydish J, Tajima B, Kulaga A, Zavala R, Brown LS, Bostrom A, Ziedonis D, Chan M. PMID: 22420814; PMCID: PMC3340008.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    62. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Depend. 2012 Feb 01; 121(1-2):30-7. Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, Chan M, Delucchi K, Zammarelli L, Levy M, Kolodziej M, Brigham G. PMID: 21906892; PMCID: PMC3335347.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    63. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011 Jun; 13(6):401-11. Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. PMID: 21464202; PMCID: PMC3103720.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    64. A Randomized Trial of Probation Case Management for Drug-Involved Women Offenders. Crime Delinq. 2011 Mar; 57(2):167-198. Guydish J, Chan M, Bostrom A, Jessup M, Davis T, Marsh C. PMID: 21464888; PMCID: PMC2699297.
      View in: PubMed   Mentions: 14  
    65. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Drug Alcohol Depend. 2011 Apr 01; 114(2-3):237-41. Guydish J, Tajima B, Chan M, Delucchi KL, Ziedonis D. PMID: 21055884; PMCID: PMC3062722.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    66. Adoption of motivational interviewing and motivational enhancement therapy following clinical trials. J Psychoactive Drugs. 2010 Sep; Suppl 6:215-26. Guydish J, Jessup M, Tajima B, Manser ST. PMID: 21138198; PMCID: PMC3349358.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    67. Investigating the effects of San Francisco's Treatment on Demand Initiative on a publicly-funded substance abuse treatment system: a time series analysis. J Psychoactive Drugs. 2009 Sep; 41(3):297-304. Sears C, Davis T, Guydish J, Gleghorn A. PMID: 19999683; PMCID: PMC2988684.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Cigarette smoking among opioid-dependent clients in a therapeutic community. Am J Addict. 2009 Jul-Aug; 18(4):316-20. Chun J, Haug NA, Guydish JR, Sorensen JL, Delucchi K. PMID: 19444736; PMCID: PMC2756535.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    69. Does the Presence of a Smoking Cessation Clinical Trial Affect Staff Practices Related to Smoking? J Drug Issues. 2009 Apr 01; 39(2):1. Chun J, Guydish JR, Delucchi K. PMID: 20057920; PMCID: PMC2802349.
      View in: PubMed   Mentions: 3  
    70. Development of the Smoking Knowledge, Attitudes, and Practices (S-KAP) Instrument. J Drug Issues. 2009 Mar; 39(2):347-364. Delucchi KL, Tajima B, Guydish J. PMID: 20717496; PMCID: PMC2921865.
      View in: PubMed   Mentions: 18  
    71. Staff Knowledge, Attitudes, and Practices Regarding Nicotine Dependence Differ by Setting. J Drug Issues. 2009; 39(2):365-384. Tajima B, Guydish J, Delucchi K, Passalacqua E, Chan M, Moore M. PMID: 20617124; PMCID: PMC2898575.
      View in: PubMed   Mentions: 10  
    72. Methadone patients in the therapeutic community: a test of equivalency. Drug Alcohol Depend. 2009 Feb 01; 100(1-2):100-6. Sorensen JL, Andrews S, Delucchi KL, Greenberg B, Guydish J, Masson CL, Shopshire M. PMID: 19013724; PMCID: PMC2606930.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    73. Knowledge and Attitudes About Methadone Maintenance Among Staff Working in a Therapeutic Community. J Maint Addict. 2005; 3(1):47-59. Andrews S, Sorensen JL, Guydish J, Delucchi K, Greenberg B. PMID: 23525520; PMCID: PMC3604981.
      View in: PubMed   Mentions: 6  
    74. Drug treatment outcomes for persons on waiting lists. Am J Drug Alcohol Abuse. 2008; 34(5):526-33. Chun J, Guydish JR, Silber E, Gleghorn A. PMID: 18618338; PMCID: PMC2766557.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ. 2008; 38(2):181-92. Haug NA, Shopshire M, Tajima B, Gruber V, Guydish J. PMID: 18724657; PMCID: PMC2742313.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    76. The Place of Adoption in the NIDA Clinical Trials Network. J Drug Issues. 2008; 38(4):1083. Jessup MA, Guydish J, Manser ST, Tajima B. PMID: 20126428; PMCID: PMC2814443.
      View in: PubMed   Mentions: 1  
    77. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. J Psychoactive Drugs. 2007 Dec; 39(4):423-33. Guydish J, Passalacqua E, Tajima B, Manser ST. PMID: 18303699; PMCID: PMC2993183.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    78. Addressing tobacco use through organizational change: a case study of an addiction treatment organization. J Psychoactive Drugs. 2007 Dec; 39(4):451-9. Ziedonis DM, Zammarelli L, Seward G, Oliver K, Guydish J, Hobart M, Meltzer B. PMID: 18303702; PMCID: PMC2981503.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    79. Smoking among adolescents in substance abuse treatment: a study of programs, policy, and prevalence. J Psychoactive Drugs. 2007 Dec; 39(4):443-9. Chun J, Guydish J, Chan YF. PMID: 18303701; PMCID: PMC2988489.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    80. Substance abuse counselor certification in California: how is nicotine addiction addressed? J Psychoactive Drugs. 2007 Dec; 39(4):473-7. Kurita K, Guydish J. PMID: 18303704; PMCID: PMC2981499.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    81. Outcomes in a Sample of Opiod-Dependent Clients Treated Under California's Proposition 36. J Drug Issues. 2007 Jul 01; 37(3):699-715. Chun J, Guydish JR, Sorensen JL, Haug NA, Andrews S, Nelson L. PMID: 22581981; PMCID: PMC3349171.
      View in: PubMed   Mentions: 1  
    82. Drug treatment utilization before, during and after pregnancy. J Subst Use. 2007 Jan 01; 12(1):27-38. Wolfe EL, Guydish JR, Santos A, Delucchi KL, Gleghorn A. PMID: 22719224; PMCID: PMC3377323.
      View in: PubMed   Mentions: 4  
    83. Access to drug abuse treatment under Treatment on Demand policy in San Francisco. Am J Drug Alcohol Abuse. 2007; 33(2):227-36. Sorensen JL, Guydish J, Zilavy P, Davis TB, Gleghorn A, Jacoby M, Sears C. PMID: 17497545; PMCID: PMC3493250.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    84. Strategies to encourage adoption in multisite clinical trials. J Subst Abuse Treat. 2007 Mar; 32(2):177-88. Guydish J, Tajima B, Manser ST, Jessup M. PMID: 17306726; PMCID: PMC3349356.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    85. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat. 2007 Jan; 32(1):53-60. Fuller BE, Guydish J, Tsoh J, Reid MS, Resnick M, Zammarelli L, Ziedonis DM, Sears C, McCarty D. PMID: 17175398; PMCID: PMC3496385.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    86. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006; 29(3):228-35. Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. PMID: 17373414; PMCID: PMC6527042.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    87. Evaluation of Probation Case Management (PCM) for Drug-Involved Women Offenders. Crime Delinq. 2005 Oct 01; 51(4):447-469. Chan M, Guydish J, Prem R, Jessup MA, Cervantes A, Bostrom A. PMID: 22719108; PMCID: PMC3377177.
      View in: PubMed   Mentions: 3  
    88. Multi-level assessment protocol (MAP) for adoption in multi-site clinical trials. J Drug Issues. 2005 Jul 01; 35(3):529-546. Guydish J, Manser ST, Jessup M, Tajima B, Sears C, Montini T. PMID: 20890376; PMCID: PMC2947142.
      View in: PubMed   Mentions: 5  
    89. Mortality risk associated with perinatal drug and alcohol use in California. J Perinatol. 2005 Feb; 25(2):93-100. Wolfe EL, Davis T, Guydish J, Delucchi KL. PMID: 15496968; PMCID: PMC3349286.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    90. Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse. 2005; 40(11):1681-96. Lum PJ, Sears C, Guydish J. PMID: 16253934.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    91. Perspectives on the drug court model across systems: a process evaluation. J Psychoactive Drugs. 2004 Sep; 36(3):379-86. Wolfe EL, Guydish J, Woods W, Tajima B. PMID: 15559684; PMCID: PMC3347910.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    92. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002 Oct 01; 31(2):237-42. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. PMID: 12394803.
      View in: PubMed   Mentions: 21  Translation:HumansCells
    93. A Drug Court Outcome Evaluation Comparing Arrests in a Two Year Follow-up Period. J Drug Issues. 2002 Sep; 32(4):1155-1172. Guydish JR. PMID: 21528100; PMCID: PMC3082148.
      View in: PubMed   Mentions: 4  
    94. Improving publicly-funded drug abuse treatment systems: the Target Cities Initiative. J Psychoactive Drugs. 2002 Jan-Mar; 34(1):1-6. Guydish J, Claus RE. PMID: 12003107.
      View in: PubMed   Mentions: 3     Fields:    
    95. The San Francisco centralized intake unit: a description of participants and service episodes. J Psychoactive Drugs. 2002 Jan-Mar; 34(1):17-24. Woods WJ, Klingemann SD, Guydish JR. PMID: 12003109.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Effects of treatment history and centralized intake on drug treatment outcomes. J Psychoactive Drugs. 2002 Jan-Mar; 34(1):87-95. Sears C, Davis T, Guydish J. PMID: 12003118.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Drug court effectiveness: a review of California evaluation reports, 1995-1999. J Psychoactive Drugs. 2001 Oct-Dec; 33(4):369-78. Guydish J, Wolfe E, Tajima B, Woods WJ. PMID: 11824696; PMCID: PMC3366587.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Does centralized intake improve drug abuse treatment outcomes? J Subst Abuse Treat. 2001 Jun; 20(4):265-73; discussion 275-6. Guydish J, Woods WJ, Davis T, Bostrom A, Frazier Y. PMID: 11672641.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    99. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. J Acquir Immune Defic Syndr. 2001 Jun 01; 27(2):193-201. Sears C, Guydish JR, Weltzien EK, Lum PJ. PMID: 11404542.
      View in: PubMed   Mentions: 14  Translation:Humans
    100. Gender differences in income after substance abuse treatment. J Subst Abuse Treat. 2001 Apr; 20(3):215-24. Oggins J, Guydish J, Delucchi K. PMID: 11516590.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    101. Relapse outcomes in a randomized trial of residential and day drug abuse treatment. J Subst Abuse Treat. 2001 Jan; 20(1):15-23. Greenwood GL, Woods WJ, Guydish J, Bein E. PMID: 11239724.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    102. Drug abuse treatment on demand in San Francisco: preliminary findings. J Psychoactive Drugs. 2000 Oct-Dec; 32(4):363-70. Guydish J, Moore L, Gleghorn A, Davis T, Sears C, Harcourt J. PMID: 11210197.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. Changes in HIV-related risk behaviors following drug abuse treatment. AIDS. 1999 Oct 22; 13(15):2151-5. Woods WJ, Guydish JR, Sorensen JL, Coutts A, Bostrom A, Acampora A. PMID: 10546869.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    104. Reorganizing publicly-funded drug abuse treatment: the experience of ten Target Cities Projects. J Psychoactive Drugs. 1999 Jul-Sep; 31(3):273-8. Guydish J, Muck R. PMID: 10533974.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. A process evaluation of the San Francisco Target Cities Project in the first year. J Psychoactive Drugs. 1999 Jul-Sep; 31(3):197-203. Guydish J, Woods W, Tajima B, Frazier Y. PMID: 10533964.
      View in: PubMed   Mentions:    Fields:    
    106. The challenge of managed care in drug abuse treatment. J Psychoactive Drugs. 1999 Jul-Sep; 31(3):193-5. Guydish J, Muck R. PMID: 10533963.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    107. A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes. J Consult Clin Psychol. 1999 Jun; 67(3):428-34. Guydish J, Sorensen JL, Chan M, Werdegar D, Bostrom A, Acampora A. PMID: 10369064.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    108. Drug abuse day treatment: a randomized clinical trial comparing day and residential treatment programs. J Consult Clin Psychol. 1998 Apr; 66(2):280-9. Guydish J, Werdegar D, Sorensen JL, Clark W, Acampora A. PMID: 9583331.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    109. Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Subst Use Misuse. 1998 Apr; 33(5):1173-96. Guydish J, Bucardo J, Clark G, Bernheim S. PMID: 9596382.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    110. Syringe use and reuse: effects of syringe exchange programs in four cities. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 Suppl 1:S37-44. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. PMID: 9663622.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    111. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS. 1997 Sep; 11 Suppl 1:S35-42. Telles PR, Bastos FI, Guydish J, Inciardi JA, Surratt HL, Pearl M, Hearst N. PMID: 9376099.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    112. Clients entering drug abuse day treatment: 18-month outcomes. Am J Drug Alcohol Abuse. 1997 Feb; 23(1):99-114. Guydish J, Werdegar D, Tajima B, Price M, Acampora A. PMID: 9048150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    113. A day treatment program in a therapeutic community setting: six-month outcomes. The Walden House Day Treatment Program. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):441-7. Guydish J, Werdegar D, Sorensen JL, Clark W, Acampora A. PMID: 8749728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    114. A visual inspection protocol for measuring characteristics of used syringes. J Subst Abuse. 1995; 7(3):319-29. Guydish J, Garcia D, Clark G, Young M. PMID: 8749791.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    115. Are bisexually identified men in San Francisco a common vector for spreading HIV infection to women? Am J Public Health. 1994 Jun; 84(6):915-9. Ekstrand ML, Coates TJ, Guydish JR, Hauck WW, Collette L, Hulley SB. PMID: 8203686; PMCID: PMC1614964.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    116. Evaluating needle exchange: are there negative effects? AIDS. 1993 Jun; 7(6):871-6. Guydish J, Bucardo J, Young M, Woods W, Grinstead O, Clark W. PMID: 8395856.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    117. Detecting HIV antibodies in needle-exchange syringes. AIDS. 1992 Jul; 6(7):739-40. Guydish J, Clark G, Garcia D, Yee J, Greenspan JS, Hearst N. PMID: 1503694.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    118. Using forensic techniques to verify self-reports of needle-sharing. AIDS. 1991 Sep; 5(9):1149-50. Gibson DR, Guydish JR, Wraxall BG, Blake ET, Clark G, Case P. PMID: 1930786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. Evaluating needle exchange: do distributed needles come back? Am J Public Health. 1991 May; 81(5):617-9. Guydish J, Clark G, Garcia D, Downing M, Case P, Sorensen JL. PMID: 2014862; PMCID: PMC1405085.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    120. Changes in sexual practices over 5 years of follow-up among heterosexual men in San Francisco. J Acquir Immune Defic Syndr (1988). 1991; 4(9):896-900. Samuel MC, Guydish J, Ekstrand M, Coates TJ, Winkelstein W. PMID: 1895211.
      View in: PubMed   Mentions: 1  Translation:Humans
    121. Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health. 1990 Aug; 80(8):995-7. Guydish JR, Abramowitz A, Woods W, Black DM, Sorensen JL. PMID: 2368868; PMCID: PMC1404792.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    122. Evaluation of a hospital based substance abuse intervention and referral service for HIV affected patients. Gen Hosp Psychiatry. 1990 Jan; 12(1):1-7. Guydish J, Temoshok L, Dilley J, Rinaldi J. PMID: 2295429.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    123. Alcohol-related cognitions: do they predict treatment outcome? Addict Behav. 1990; 15(5):423-30. Guydish J, Greenfield TK. PMID: 2248115.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    124. Changes in needle sharing and syringe cleaning among San Francisco drug abusers. N Engl J Med. 1989 Mar 23; 320(12):807. Sorensen JL, Guydish J, Costantini M, Batki SL. PMID: 2922030.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    125. Reasons students give for limiting drinking: a factor analysis with implications for research and practice. J Stud Alcohol. 1989 Mar; 50(2):108-15. Greenfield TK, Guydish J, Temple MT. PMID: 2927125.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    126. Helping behavior of females: effects of stress and commonality of fate. J Psychol. 1984 Jul; 117(2D Half):233-7. Hayden SR, Jackson TT, Guydish J. PMID: 6492017.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    127. Behavior modification: doing battle in the ethical arena. J Behav Ther Exp Psychiatry. 1982 Dec; 13(4):315-20. Guydish J, Kramer JJ. PMID: 7166604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Joe's Networks
    Concepts (279)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (37)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California